Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis.

Abstract

BACKGROUND Acute exacerbation of chronic bronchitis (AECB) places tremendous burden on patients, providers, employers, and health care systems. OBJECTIVE The purpose of this paper is to (1) review the clinical, patient-reported, and economic measures used to evaluate disease burden and treatment effectiveness in AECB in clinical trials and (2) propose a… (More)

Topics

Cite this paper

@article{Perfetto2001SelectionOC, title={Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis.}, author={Enrico Perfetto and C. Daniel Mullins and Prasun Subedi and Josephine M Li-McLeod}, journal={Clinical therapeutics}, year={2001}, volume={23 10}, pages={1747-72} }